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G-protein regulationFamilial hemiplegic migraine type 1 (FHM-1) is a monogenic form of migraine with aura that is characterized
by recurrent attacks of a typical migraine headache with transient hemiparesis during the aura phase. In a
subset of patients, additional symptoms such as epilepsy and cerebellar ataxia are part of the clinical
phenotype. FHM-1 is caused by missense mutations in the CACNA1A gene that encodes the pore-forming
subunit of CaV2.1 voltage-gated Ca
2+ channels. Although the functional effects of an increasing number of
FHM-1 mutations have been characterized, knowledge on the inﬂuence of most of these mutations on G
protein regulation of channel function is lacking. Here, we explored the effects of G protein-dependent
modulation on mutations W1684R and V1696I which cause FHM-1 with and without cerebellar ataxia,
respectively. Both mutations were introduced into the human CaV2.1α1 subunit and their functional
consequences investigated after heterologous expression in human embryonic kidney 293 (HEK‐293) cells
using patch-clamp recordings. When co-expressed along with the human μ-opioid receptor, application of
the agonist [D‐Ala2, N‐MePhe4, Gly‐ol]‐enkephalin (DAMGO) inhibited currents through both wild-type
(WT) and mutant CaV2.1 channels, which is consistent with the known modulation of these channels by G
protein-coupled receptors. Prepulse facilitation, which is a way to characterize the relief of direct voltage-
dependent G protein regulation, was reduced by both FHM-1 mutations. Moreover, the kinetic analysis of the
onset and decay of facilitation showed that the W1684R and V1696I mutations affect the apparent
dissociation and reassociation rates of the Gβγ dimer from the channel complex, suggesting that the G
protein-Ca2+ channel afﬁnity may be altered by the mutations. These biophysical studies may shed new light
on the pathophysiology underlying FHM-1.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Migraine is a disabling neurovascular disorder that affects ~20% of
the general population [1]. The disease is characterized by recurrent
attacks of severe headache and associated autonomic symptoms, such
as nausea and vomiting as well as photo- and phonophobia. In about
one-third of the patients, the headache is preceded by transient
focal neurological symptoms (aura). Although migraine etiology and
genetic inﬂuences at the population level are unknown, recent
genome-wide association studies have identiﬁed the ﬁrst genelogía Celular, Cinvestav-IPN,
07300, Mexico. Tel.: +52 55
l rights reserved.variants for migraine. These ﬁndings connect a disturbed neuronal
glutamate signaling with the pathophysiology of the disease [2,3].
Until now, the molecular insights on migraine pathophysiology
came from studies on familial hemiplegic migraine (FHM), a
monogenic subtype of migraine with aura. FHM can be considered a
model for common migraine, because attacks in FHM patients are
very similar to those in the common types, except for a long-lasting
hemiparesis during the aura phase [4,5], and also because the FHM
patients may exhibit migraine attacks with or without aura. Likewise,
in FHM patients the clinical phenotype can also include epilepsy and/
or cerebellar abnormalities ranging from nystagmus to progressive
mild ataxia [6,7]. Three genes are known to be associated with FHM.
Mutations in CACNA1A and SCN1A, encoding the ion-conducting
subunits of the neuronal voltage-gated P/Q-type Ca2+ (CaV2.1α1)
and Na+ (NaV1.1) channels, are responsible for FHM types 1 and 3
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the α2 subunit of the Na+–K+ ATPase, are responsible for FHM-2
[5,7–10].
The functional consequences of 13 of the 21 FHM-1 mutations in
the CACNA1A gene have been tested for their consequences on Ca2+
channel function using electrophysiology in heterologous expression
systems [8–11]. These studies have shown that the mutations alter
different properties of the human CaV2.1 channel. For instance, an
enhanced channel open probability and increased single channel
calcium inﬂux associated to a shift to lower voltages of channel
activation has been reported in HEK-293 cells and in CaV2.1α1 null
neurons transfected with FHM-1 mutant CaV2.1 channels [12,13].
Likewise, a decreased density of functional channels and a conse-
quent decreased maximal whole-cell Ca2+ current density has also
been reported for many FHM-1 mutants [12–14]. Investigation of the
functional consequences of FHM-1 gene mutations R192Q and S218L
in transgenic knock-in mice [15,16], revealed increased whole cell
current densities, which are in line with single channel measure-
ments, as well as increased cortical glutamatergic neurotransmitter
release [17], indicating that FHM-1 mutations more likely exert
channel gain-of-function [10,11].
Much less is known, however, regarding the effects of FHM-1
mutations on the modulation of CaV2.1 channels by G proteins.
Although no FHM-1 mutation has been found in the channel region
involved in G-protein binding, initial studies revealed a reduction of
G-protein-mediated channel inhibition by speciﬁc FHM-1 mutations
[18–20], an effect that may lead to altered Ca2+ inﬂux through
mutant channels during neuromodulation. Here, we studied the
functional consequences of two FHM-1 mutations (W1684R and
V1696I) located in the fourth repeat domain of the CaV2.1α1 subunit
on G-protein-mediated inhibition. Our results show that both
mutants might have compromised G-protein coupling.
2. Materials and methods
2.1. Cell culture, cDNA clones and transfection
Human embryonic kidney 293 (HEK‐293) cells (ATCC, Manassas,
VA) were maintained in Dulbecco's modiﬁed essential medium-high
glucose supplemented with 10% horse serum, 1% L-glutamine,
110 mg/L sodium pyruvate and antibiotics, at 37 °C in a 5% CO2–95%
air humidiﬁed atmosphere. Gene transfer was performed using
Lipofectamine Plus reagent (Invitrogen, Carlsbad, CA) as described
previously [19]. Brieﬂy, for a 35-mm Petri dish of HEK-293 cells, 2 μg
of the plasmid cDNA encoding the WT or the mutant variants of the
human CaV2.1 (P/Q-type) Ca2+ channel pore-forming subunit splice
isoform 1A-2 (GenBank accession number AF004883) [21]; in
combination with 2 μg cDNA of the rat brain CaVβ3 (M88751) [22];
and 2 μg cDNA coding the WT rat brain CaVα2δ-1b cDNA (M86621)
[23] were premixed with 6 μL of Lipofectamine in 100 μL serum-free
medium according to the manufacturer's instructions. The solution
was then added to the dish and cells grown at 37 °C for 24 h, when
medium was changed.
FHM-1 mutations were introduced into the human full-length
cDNA encoding the CaV2.1α1 subunit of the neuronal CaV2.1 (P/Q-
type) Ca2+ channel as previously described [24]. Mutant PCR products
harboring either mutation W1684R or V1696I were subcloned into a
mammalian expression vector, and sequences were veriﬁed by DNA
sequencing. The cDNA coding for the human μ-opioid receptor
(hMOR; AY521028) was obtained from the UMR cDNA Resource
Center www.cdna.org and used as previously reported [19,25].
2.2. SDS-PAGE and Western blots
Total extracts from transfected HEK-293 cells as well as frommouse
brain (used as control), were prepared as described elsewhere [26,27].Brieﬂy, cells were harvested, washed twice with PBS and homogenized
during 20 min in cold lysis buffer (50 mM Tris–HCl pH 8.0, 150 mM
NaCl, 0.5 mM PMSF, 1% of Triton X-100 and 1× complete—Roche
Applied Science). Homogenized samples were clariﬁed by a 12,000×g
centrifugation step for 2 min. The supernatant was stored at −70 °C.
Aliquots of 100 μg of protein were mixed with sample buffer
(50 mM Tris–HCl, 1.7% SDS, 5% glycerol, and 0.002% bromophenol
blue) and boiled for 5 min. Samples were subjected to 10% SDS-
PAGE electrophoresis and proteins were transferred to a nitrocellu-
lose membrane (Hybond-N; GE Healthcare, Buckinghamshire, UK).
After blocking with non-fat milk (5%) in TBS-T (100 mM Tris–
HCl, 0.15 M NaCl, 0.05% Tween 20), membranes were incubated
overnight with the primary anti-hMOR antibody (Invitrogen; Cat.
# 44-308G) 1:1000 in TBS-T with 5% non-fat milk, washed in TBS-T,
incubated with horseradish peroxidase goat anti-rabbit secondary
antibody and developed with the Immobilon Western Chemilumi-
nescent HRP Substrate (Millipore) according to the manufacturers'
instructions.
2.3. Electrophysiological recordings
Ionic currents from HEK-293 cells were recorded 48 h after
transfection at room temperature (~22 °C) using the whole-cell
conﬁguration of the patch-clamp technique [28]. Ba2+ was used as
the charge carrier. The extracellular solution contained (in mM):
BaCl2, 10; TEA-Cl, 125; HEPES, 10; and glucose, 10 [pH 7.3]. The
intracellular solution contained (in mM): CsCl, 110; MgCl2, 5; EGTA,
10; HEPES, 10; Na-ATP, 4; and GTP, 0.1 [pH 7.3]. Recordings were
performed using an Axopatch 200B ampliﬁer (Axon Instruments,
Foster City, CA). Currents were digitized at a sampling rate of 5.7 kHz
and ﬁltered at 2 kHz (four-pole Bessel ﬁlter). Linear leak and parasitic
capacitance components were subtracted on-line using a P/4
protocol. Membrane capacitance (Cm) was determined as previously
described [29] and used to normalize currents.
2.4. Data analysis
Current–voltage (I–V) relationships were obtained by step
depolarization between−50 mV and +70 mV in 10 mV increments,
from a holding potential (Vh) of −80 mV. To assess steady-state
inactivation properties, a 2-s conditioning pulse to various potentials
preceded a test depolarization to +10 mV. Inactivation curves were
ﬁtted with a Boltzmann function IBa= Imax/(1+exp[(Vm−V1/2) /k]),
where the current amplitude (IBa) has decreased to a half-amplitude
at V1/2 with an e-fold change over kmV. Current remaining was
measured from an average of 3 individual sweeps per recording using
the equation: Irem=100*(Iend/Ipeak), where Irem is the current
remaining at the end of a 140-ms test pulse, Iend is the value at the
end of the test pulse, and Ipeak is the maximum current measured
during the test pulse. Time constant (τ) of inactivation was obtained
from single exponential ﬁts of IBa decaying phase using 140-ms test
pulse to +10 mV.
The voltage-dependence of IBa inhibition by the G-protein Gβγ
dimer was examined by applying a family of 25-ms pulses to various
voltages (between −50 mV and +70 mV in 10 mV steps) 500 ms
after (P1) and 5 ms before (P2) a 50-ms conditioning prepulse to +
100 mV, from a Vh of −80 mV. Facilitation at different voltages was
then determined as the ratio IBa (P2/P1). Facilitation decay and
development (Gβγ reassociation and dissociation to the CaV2.1
channel, respectively) was studied as previously reported [18,20]
applying a three-pulse voltage protocol (Fig. 3A). Facilitation decay
was estimated applying two 25-ms test pulses (P1 and P2) to +
10 mV separated by a conditioning prepulse to +100 mV (PP), and
varying the time between PP and P2 (from 5 to 45 ms). Facilitation
development was studied using a similar three-pulse voltage protocol
varying the duration of the conditioning prepulse (from 2 to 15 ms).
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exponentials in order to obtain the corresponding time constants (τ).
The time constant of dissociation and re-association (τoff and τon)
were estimated by ﬁtting the data to monoexponential equations of
the form: P2/P1=1+ Imax[1−exp(−Δt/τoff)] or P2/P1=1+ Imax
[exp(−Δt/τon)], respectively, where P1 and P2 are the maximum
currents before and after the strong depolarizing prepulse, 1+ Imax is
the maximum ratio of facilitation and Δt is the interpulse duration or
prepulse duration, respectively.
2.5. Structural modeling of the segments S4 and S5 of domain IV in the
CaV2.1α1 subunit
Homology models of transmembrane segments IVS4 and IVS5 as
well as the S4–S5 linker domain (residues 1653–1710) in the
CaV2.1α1 subunit were generated using the Robetta server (http://
robetta.bakerlab.org). The structure of the Shaker potassium KV1.2
channel model [30] was used as a template. Five models were
generated and validated using the Structural Analysis and Veriﬁcation
Server (http://nihserver.mbi.ucla.edu/SAVES/Info.php) and the model
with the best quality parameters was chosen for analysis. Compu-
tational methods for assigning partial charges and determining
electrostatic potentials were applied using the Swiss-PdbViewer
software (http://www.expasy.org/spdbv/). Electrostatic potentials
and free energies were obtained by using a method based on the
full nonlinear solution of the Poisson–Boltzmann equation [31].
3. Results
The neuronal CaV2.1 Ca2+ (P/Q-type) channel contains a pore-
forming CaV2.1α1 (formerly α1A) subunit and several regulatory
subunits including CaVα2δ and CaVβ. The CaV2.1α1 subunit consists of
four repeated domains (I–IV) each containing six transmembrane
regions (S1–S6), voltage sensors in S1–S4 and a pore loop between S5
and S6. The two FHM-1 mutations studied here (W1684R andFig. 1. FHM-1 mutations W1684R and V1696I may affect recombinant CaV2.1 channel activi
CaV2.1α1 subunit. B: Left panel, representative currents illustrating the magnitude and kine
obtained by applying depolarizing pulses to +10 mV during 250 ms from a holding potentia
density WT and mutant channels; currents obtained as indicated in the left panel were nor
curves of currents through WT or mutant channels as indicated. Currents were elicited by
followed by a test pulse to +10 mV. The individual data points are means of 6–8 recorded
function. V1/2 values were−47.55,−39.49 and−43.89 mV for WT and FHM-1 mutant W16
(left panel) and percentage of current remaining (right panel) at the end of the 140-ms voltaV1696I) are located in conserved regions of the S4–S5 loop of
repeated domain IV and S5 segment of domain IV, respectively
(Fig. 1A). Though seminal work by Müllner and co-workers revealed
that W1684R and V1696I FHM-1 mutations expressed in Xenopus
oocytes alter CaV2.1 channel gating and these changes depended on
the CaVβ subunit associated to the channel complex [24], the authors
did not address the question of mutant-induced changes in G-protein
regulation.
We ﬁrst characterized the impact of W1684R and V1696I FHM-1
mutations on current density and to this end, we transiently
expressed CaV2.1α1 channels in HEK-293 cells along with CaVβ3 and
CaVα2δ-1 auxiliary subunits, and whole-cell Ba2+ currents (IBa) were
recorded 2 days after transfection. The presence of the mutations was
veriﬁed by DNA sequencing (Suppl. Fig. 1). IBa densities resulting from
expression of mutant W1684R and V1696I FHM-1 mutations were
decreased in comparison with current density recorded in WT CaV2.1
channels (Fig. 1B). The potential for half-maximal activation was
shifted ~5 mV to hyperpolarized potentials for the W1684R mutant
channels, without changing the steepness of the I–V curve or the
apparent reversal potential (Fig. 2). Likewise, the half-maximal
voltage for steady-state inactivation induced by conditioning prepulses
ranging −110 to +50mV was right-shifted ~5 mV in both W1684R
and V1696I channels (Fig. 1C). Such an effect was accompanied by a
signiﬁcant slowdown in IBa decay during a 140-ms test pulses evoked
from a Vh of −80 mV to +10mV. To quantify this effect, inactivation
time constants (τinact) were obtained by ﬁtting a single-exponential
function to the decaying phases of CaV2.1 currents.W1684R and V1696I
mutations increased τinact∼2-fold, and in consequence the current
remaining at the end of the depolarizing pulse was also signiﬁcantly
increased (Fig. 1D).
Given that leftward shifts in voltage-dependence of activation and
slowed inactivation rate have been reported to facilitate recovery
from direct G protein regulation [19], we therefore investigated the
effects of the W1684R and V1696I FHM-1 mutations on voltage-
dependent Gβγ-mediated inhibition of recombinant CaV2.1 channels.ty in HEK-293 cells A: Locations of the two mutations in the secondary structure of the
tics of WT (top trace) and W1684R (middle trace) and V1696I (bottom trace) channels
l (Vh) of−80 mV. Scale bar: 200 pA; 50 ms. Right panel, average percentage of current
malized to cell capacitance (Cm). n=10–12 recorded cells. C: Steady-state inactivation
a 2-s conditioning pulse from a Vh of −80 mV in 10 mV steps from −90 to +40 mV
cells. Error bars reﬂect standard errors, and the solid lines reﬂect ﬁts via a Boltzmann
84R and V1696I channels, respectively. D: Comparison of time constant of inactivation
ge-step (Irem) in cells expressing WT and FHM-1 mutant channels. n=10–12; *Pb0.05.
Fig. 2. Receptor-mediated G-protein regulation of WT and FHM-1 W1684R and V1696I
mutant channels. A: Western blotting with a hMOR antibody on membranes from HEK-
293 cells transfected with the CaV2.1α1/CaVα2δ-1/CaVβ P/Q-type channel and the human
μ-opioid receptor (+hMOR); untransfected cells (−hMOR) and mouse brain lysate
(mBr) were used as controls. Data are representative of three independent experiments.
B–D: Current density–voltage relationships for WT, W1684R and V1696I channels
expressed in HEK-293 cells (n=8–10 recoded cells) in the absence and presence of
DAMGO as indicated. The asterisks denote statistically signiﬁcant differences (*Pb0.05).
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was examined after co-expressing the μ-opioid receptor (hMOR)
using [D-Ala2, N-MePhe4, Gly-ol]-enkephalin (DAMGO), a synthetic
opioid peptide with high speciﬁcity for hMOR. It is well known that
hMORs couple to pertussis toxin (PTX)-sensitive Gi/Go G-proteins to
inhibit Ca2+ channels [32].
IBa was recorded from HEK-293 cells transiently transfected with
either WT or FHM-1 mutant channels together with hMOR.
Expression of hMOR was examined by Western blot analysis using a
commercially available polyclonal antibody raised against a synthetic
peptide derived from an internal region of the receptor (see MaterialsFig. 3. FHM-1 mutations W1684R and V1696I alter G protein-mediated channel regulat
inhibition. The protocol consists of a voltage-step to +10 mV both before (P1) and after (
inhibition by 10 μm DAMGO before (P1) and after (P2) a 50-ms depolarizing prepulse to +
5 ms after the prepulse. Currents are superposed to facilitate comparison. C: Comparison of
V1696I channels. Currents after the prepulse were normalized to the maximal current amp
amplitude facilitation versus test potential. n=12–28 recorded cells; *Pb0.05.and methods). Fig. 2A shows that hMOR immunoreactivity was
present both in the mouse brain (used as a positive control) and in
hMOR-transfected HEK-293 cells. The identity of the labeled protein
band as hMOR was conﬁrmed by the expected size of the protein
which migrated at an apparent molecular mass of ∼50 kDa in 10%
SDS-PAGE and the absence of staining when HEK-293 cells were
mock-transfected.
Functional studies showed that exposure to 10 μM of DAMGO
produced a rapid (within 10 s) voltage-dependent inhibition of the
current through WT CaV2.1α1/CaVβ3/α2δ-1 channels of about 50%
(Fig. 2B). The inhibition was also present at the peak IBa (0 to +
10 mV) in both WT and FHM-1 mutant channel expressing cells
(Fig. 2C and D); though DAMGO reduced IBa only ~20% in cells
expressing W1684R or V1696I mutant channels. As current ampli-
tudes were measured at their peak, these differences may reﬂect
facilitated recovery from G protein inhibition occurring during
membrane depolarization, therefore occurring between the start of
the depolarization and the time to peak of the current [19].
One key feature of G protein modulation of CaV channels is its
transient relief by a strong depolarizing prepulse. This phenomenon
called facilitation is attributed to the dissociation of Gβγ dimers as
channels undergo conformational changes in response to depolariza-
tion [18–20]. We took advantage of it to explore whether FHM-1
mutations alter the recovery from G protein mediated channel
inhibition. Fig. 3B shows current traces through WT or mutant
channels recorded during inhibition by DAMGO and elicited by 25-ms
test pulses to the indicated potentials before (P1) and after (P2) the
prepulse (PP) to +100 mV (Fig. 3A). Co-expression of CaV2.1α1 WT
or the FHM-1 mutations together with CaVβ3 and CaVα2δ-1 subunits
in HEK-293 cells resulted in current facilitation (larger P2 than P1
currents following the PP), reﬂecting the voltage-dependent relief of
Gβγ-mediated channel inhibition.
Notably, in the presence of DAMGO the amplitudes of the currents
through WT and FHM-1 mutant channels were facilitated at test
potentials ranging from −10 to +20 mV (not shown). However, a
clear difference in the magnitude of facilitation was observed. Both
WT and mutant channels exhibited maximum facilitation at 0 mV,
which was 1.58±0.12 for WT, 1.36±0.06 for W1684R and 1.39±
0.07 for V1696I channels. The biggest reduction in facilitation was
observed at +10 mV. At this potential, facilitation was signiﬁcantly
reduced from 1.47±0.05 in theWT condition to 1.11±0.03 and 1.36±
0.03 for W1684R and V1696I channels, respectively (Fig. 3C).
The lower level of DAMGO-mediated inhibition observed for the
W1684R and V1696I mutant channels (Fig. 2) associated to a smaller
extent of facilitation (Fig. 3), is consistent with changes in theion. A: Depolarizing prepulse protocol used to relieve voltage-dependent G protein
P2) a depolarizing prepulse to +100 mV. B: Representative currents recorded during
100 mV. Test depolarizations to the indicated potential were given 500 ms before and
prepulse current facilitation recorded at 0 mV from cells expressing WT, W1684R and
litude before the prepulse and then averaged. The histograms represent mean current
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inhibitory pathway. It is worth mentioning that one of the major
inhibitory pathways controlling CaV channel activity at the synaptic
level is mediated precisely by G-protein coupled receptor activation.
In this context, the FHM-1 mutations may contribute to maintain Ca2+
inﬂux through CaV2.1 channels especially during high synaptic activity
by promoting channel de-inhibition.
Combined, the two parameters mentioned above reﬂect either,
i) a lower level of Gβγ-mediated inhibition on the mutant channels, or
ii) a facilitated de-inhibition during the test pulse at higher voltages.
Therefore, we sought to determine the mechanism underlying this
difference. To this end, we evaluated the time course for re-inhibition
(at −80 mV) following facilitatory depolarization (facilitation decay)
and for relief from inhibition (at +100 mV; facilitation onset),
reﬂecting the association and dissociation rates of Gβγ dimers to/
from the channel, respectively. The time constants for the onset and
decay of facilitation can be measured by varying the parameters of
the three-pulse voltage protocol. To monitor the onset of facilitation,
the ratio of current amplitudes measured before and after the
prepulse was plotted as a function of the conditioning pulse duration
(Fig. 4A and B). For each cell, facilitation was ﬁtted by a single
exponential to obtain a time constant (τ dissociation; Fig. 4C). As can
be seen in Fig. 4D, facilitation developed with an averaged time
constant of 4.9±0.5 ms for WT, 2.1±0.5 ms and 3.8±1.1 ms for
W1684R and V1696I FHM-1 mutant channels, respectively. These
results indicate that both FHM-1mutations favor G protein dissociation
from the channel during membrane depolarization.
The decay of facilitation was monitored by plotting the ratio of
current amplitudes measured before and after the prepulse as a
function of a variable interval between the conditioning prepulse
and the second test pulse (Fig. 5A and B). For each cell, the decayFig. 4. FHM-1 mutations W1684R and V1696I accelerate the apparent rate of G protein disso
dependent G protein dissociation from the channel. Prepulse duration varied from 2 to 15 m
voltage protocol were delivered at 20-s intervals. B: Representative current traces record
development) recorded from HEK-293 cells expressing the WT, W1684R and V1696I channe
of facilitatory prepulse duration for WT and FHM-1 mutant channels. D: Comparison of the t
recorded cells; *Pb0.05.of facilitation was ﬁtted by a single exponential to obtain a
time constant (τ re-association; Fig. 5C). Facilitation decayed with
an averaged time constant of 27.8±2.7 ms for WT, 15.2±3.1 ms
and 10.5±1.0 ms for W1684R and V1696I channels, respectively
(Fig. 5D).
It is well established that the onset and decay of prepulse
facilitation during Gβγ-induced inhibition can be represented by
a simple two-state model (Fig. 6A) [18,33–35], where CaV2.1α1
corresponds to the closed state of the channel, kon is the association
kinetic constant and koff is the dissociation kinetic constant, both of
them likely to have intrinsic voltage dependencies. During a
facilitating depolarization to +100 mV, the Gβγ dimers should
dissociate from the channels (Fig. 4). If Gβγ subunits do not also
rebind channels during the depolarization, then koff can be approx-
imated by 1/τoff. On repolarization to −80 mV, Gβγ dimers should
rebind to channels at a rate equal to kon[Gβγ]+koff. If at resting the
inhibition of the channels by the Gβγ dimers is strong, as suggested
by the results in Fig. 4, then koff should be small, and kon [Gβγ] can be
approximated by 1/τon [36].
Our results revealed that the time constants for Gβγ dissociation
were different for WT and W1684R mutant channels (Fig. 4).
Although our measurements reﬂect only the Gβγ association rate to
the closed channel and the dissociation rate from the open channel,
and do not allow an analysis at intermediate conformational states,
the results clearly show that both mutations accelerates Gβγ
dissociation from the channel. Hence, the estimated off-rate [koff
(s−1)] in our kinetic analysis was ~204 for the WT CaV2.1α1 subunit
and ~261 and ~483 for the W1684R and V1696I mutant subunits,
respectively, with a relative increase of ~1.3 and 2.4 fold (Fig. 6B). On
the other hand, assuming an intracellular concentration of 50 nM for
the Gβγ dimer [35], as well as that the interaction with the channelsciation from CaV2.1 channels. A: Depolarizing prepulse protocol used to study voltage-
s, and the interpulse intervals were ﬁxed to 500 and 5 ms. Successive episodes of this
ed during inhibition by 10 μm DAMGO of relief of G-protein regulation (facilitation
ls. C: Comparison of time course of facilitation development (P2/P1 ratio) as a function
ime constant of G protein dissociation fromWT and FHM-1 mutant channels. n=10–15
Fig. 5. FHM-1 mutation V1696I slows down the apparent rate of G protein association from P/Q channels. A: Depolarizing prepulse protocol used to study voltage-dependent G
protein reassociation to the channel. The interval between the ﬁrst test pulse, P1, and the prepulse (PP) was 500 ms; the interval between PP and the second test pulse, P2, (Δt)
varied from 5 to 45 ms. B: Representative current traces recorded during inhibition by 10 μm DAMGO of re-inhibition by G proteins (facilitation decay) of WT and FHM-1 mutant
channels, as indicated. Successive episodes of this voltage protocol were delivered at 20-s intervals. C: Comparison of time course of facilitation decay (P2/P1 ratio) as a function of
interpulse duration for WT and FHM-1 mutant channels. D: Comparison of the time constant of G protein dissociation from WT and FHM-1 mutant channels. n=10–11 recorded
cells; *Pb0.05.
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[Gβγ] (s−1)] was 0.7, 1.3 and 1.9×109 (M−1 s−1) for the WT, the
W1684R and the V1691I subunits, respectively. These alterations in
kinetics may help explain the apparent reduced voltage-dependent
inhibition by G proteins of the CaV2.1 mutant channels.Fig. 6. FHM-1 mutations W1684R and V1696I alter the kinetics of prepulse facilitation.
A: Simple kinetic scheme representing the binding of the Gβγ dimer of G-proteins to
WT and FHM-1 mutant CaV2.1α1 subunits. The channels are assumed to have G protein
bound (CaV2.1α1/Gβγ) and unbound (CaV2.1α1+Gβγ) states modulated by transition
rates (Kon and Koff). Arrows represent transition rates between states. B: Estimated
kinetic constant values for the FHM-1 mutations W1684R and V1696I normalized and
plotted as fold change with respect to WT channels.It is worth noting that there was a difference in the Kd of Gβγ
binding to the FHM-1 (V1696IbWTbW1684R). Though the reason
for the difference in the afﬁnity of the Gβγ dimer for the mutant
channels is presently unknown, it is tempting to speculate that
differences like this might be related to electrostatic potential
changes occurring in the channels due to the presence of the
mutations. It is well-known that the electrostatic potential plays an
important role in many biological processes including folding,
conformational stability, enzyme activity and protein–ligand or
protein–protein interactions [37–39].
Given that hydrophobic interactions and electrostatic comple-
mentarity are important for high-afﬁnity interactions, we decided to
model the segments 4 and 5 of domain IV as well as the cytoplasmic
loop connecting these two transmembrane segments in the CaV2.1α1
subunit (where the studied mutations are located) and determine its
electrostatic potential. Our analysis showed that the V1696I mutation
did not result in any change in the electrostatic potential in the region
analyzed. However, the electrostatic potential was drastically affected
by theW1684Rmutation (Fig. 7) due to the substitution of a nonpolar
amino acid (tryptophan) for a polar one (arginine). Interestingly,
patients bearing the W1684R mutation, but not the V1696I mutation,
have been shown to exhibit cerebellar ataxia as part of their
phenotype [6].
4. Discussion
CaV2.1 (P/Q-type) channels are abundant in the mammalian brain
where they mediate Ca2+ inﬂux across presynaptic and somatoden-
dritic membranes, thereby triggering neurotransmitter release and
other key neuronal responses [40]. Because of its high expression
level in the brain, the pore-forming (α1A) subunit of the CaV2.1
Fig. 7. Electrostatic potential distribution in the transmembrane segments 4 and 5 of domain IV of the CaV2.1α1 channel subunit. The ﬁgure shows the most probable 3D model of
the CaV2.1α1 subunit motif IVS4 (yellow), IVS5 (green) and the cytoplasmic loop connecting both transmembrane segments (white). The electrostatic potential of the analyzed
region in the wild-type sequence (WT) and in the two mutants (W1684R and V1696I) is shown in red (negative) and blue (positive). Tryptophan and valine in the WT sequence as
well as arginine and isoleucine amino acid residues in the mutant channel sequences are all shown in magenta.
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cloning [41,42]. Its importance also comes from the fact that
mutations in the CaV2.1α1 subunit can cause neurological diseases
such as FHM-1, episodic ataxia type 2 (EA-2) and spinocerebellar
ataxia type 6 (SCA-6) [43,44].
Inhibition of CaV2.1 channels by G protein coupled receptors is
widespread and is important for controlling neurotransmitter release.
The complexity of this protein signaling mechanism is vast and
involves distinct pathways that may converge on these channels.
Perhaps the most prominent is the so-called voltage-dependent
inhibitionmediated by direct binding of the G protein βγ dimer to the
CaV2.1α1 subunit of the channel [45-48]. Characteristic features of
this modulation mechanism include a reduction in current amplitude,
a slowdown in activation kinetics, and the development of prepulse
facilitation during G protein regulation. These characteristics have been
incorporated into models in which the CaV2.1 channels exhibit two
functional gating states, “willing” and “reluctant” [48]. The reluctant
channels are bound to Gβγ and display the voltage-dependent shifts in
channel gating noted above.
Previous functional studies have investigated the response to G
protein modulation of three different FHM-1 mutant channels
[18–20]. Using recombinant CaV2.1 channels expressed in tsA-201
cells along with the dopamine D2 receptor, initial studies showed that
the extent of G protein-mediated inhibition and the prepulse
facilitation were reduced by the FHM-1 R192Q mutation. Since this
mutation did not alter facilitation onset and decay or slow activation,
it was suggested that the Gβγ-CaV channel afﬁnity was not affected
and that the consequences of the mutation were restricted to
allosteric modiﬁcations that occurred after the Gβγ dimer bound to
the channel [18]. More recently, we determined the functional
consequences of, again, FHM-1 R192Q and mutation S218L mutations
on G-protein regulation of CaV2.1 channels expressed in HEK-293
cells along with human μ-opioid receptors. Our results show that
these mutations did not affect association of the Gβγ dimer onto thechannel in the closed state but, in contrast to the results previously
reported for R192Q, both mutations facilitated Gβγ dissociation from
the activated channel, thereby decreasing the inhibitory G-protein
pathway [19]. Similarly, more recently, it has been reported that also
FHM-1 mutation Y1245C reduces G protein channel inhibition by
favoring the dissociation of the Gβγ dimer from the channel [20].
Our data provide the ﬁrst detailed evidence that W1684R and
V1696I mutations cause conformational changes in the CaV2.1α1
subunit which result in alterations in the Gβγ-mediated inhibitory
pathway. In particular, the results indicate that both FHM-1
mutations favor G protein dissociation from the channel during
membrane depolarization. In a physiological context, this effect on G-
protein regulation should contribute to render the neuronal network
hyperexcitable, possibly as a consequence of reduced presynaptic
inhibition, and help explain some aspects of the pathophysiology of
FHM-1.
Likewise, studies in heterologous expression systems have shown
that FHM-1 mutations may alter channel properties in a complex
way, leading to both gain- and loss-of-function [10,11,49]. Our data
suggest that the FHM-1 mutations W1684R and V1696I may
inﬂuence CaV2.1 channels by affecting the dissociation of the Gβγ
dimer. Although, a reduced channel density was observed in our data
that could qualify as a possible mechanism (Fig. 1B), there is general
consensus that a reduction of current density is more likely due to the
method of heterologous expression given that no current reduction is
observed when FHM-1 mutations are expressed in a more physio-
logical environment, i.e. in knock-in mouse mutants [15,16]. Also the
evidence that a reduction of mutant CaV2.1 expression results in EA-2,
not FHM-1, would be in line with this.
Lastly, it is not entirely clear how alterations associated with FHM-
1 mutations play a role in the pathogenesis of the disease, but a
favored hypothesis considers neuronal hyperexcitability in the
cerebral cortex as the basis for susceptibility to disease [50]. Although
the effects of the W1684R and V1696I mutations on overall neuronal
1245E. Garza-López et al. / Biochimica et Biophysica Acta 1822 (2012) 1238–1246excitability is difﬁcult to predict, an increased postsynaptic excitability
might result from this gain-of-function variants of presynaptic
channels controlling release of excitatory neurotransmitters. Hence,
in addition to altered response to direct G-protein regulation, it is
possible that the mutations might interfere also with other molecular
signaling important for neurotransmitter vesicle release. Though the
two FHM-1 mutations reported here are located in conserved regions
of the Cav2.1α1 subunit (Fig. 1A) where no interaction sites with
proteins of the exocytoticmachinery has been reported, the possibility
exists, that the altered responses of the mutant channels to G-protein
regulation could result from inappropriate indirect interactions with
such proteins. This is an interesting topic for future studies.
Supplementary related to this article can be found online at http://
dx.doi.org/10.1016/j.bbadis.2012.04.008.
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